-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Overweight on Viatris, Raises Price Target to $17

Benzinga·03/24/2026 14:10:54
Listen to the news
Barclays analyst Glen Santangelo maintains Viatris (NASDAQ:VTRS) with a Overweight and raises the price target from $15 to $17.